Prot #ADCT-901-101: A Phase 1, Open-Label, Dose-Escalation and Dose-Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of ADCT-901 as Monotherapy in Patients With Selected Advanced Solid Tumors

Project: Research project

Project Details

StatusActive
Effective start/end date4/27/224/27/25

Funding

  • Clinipace, Inc. (Prot #ADCT-901-101)
  • ADC Therapeutics Sarl (Prot #ADCT-901-101)